BLGO
BIOLARGO, INC.Company Information
- Company Name
- BIOLARGO, INC.
- CIK
- CIK0000880242
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- BLGO: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 2800
- SIC Description
- Chemicals & Allied Products
- Ticker
- BLGO
SEC filing data through
Insider Sentiment
- Last purchase
- 2018-03-23
- Last sale
- —
- Shares purchased (TTM)
- 172,428
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 117,838
- Shares outstanding
- 318,698,686
- Ownership
- 0.04%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -10.00%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 2 | 4 | 4 | 5 | 3 | 3 | 4 | 4 | 5 | 4 | 4 | 3 | ||||||
| Accounts Receivable Net Current | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 3 | 2 | 2 | 3 | 1 | ||||||
| Notes And Loans Receivable Net Current | - | - | - | - | 3 | - | - | - | - | - | - | - | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 3 | 5 | 5 | 6 | 9 | 7 | 7 | 7 | 7 | 7 | 6 | 5 | ||||||
| Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finance Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Prepaid Expense Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Notes And Loans Receivable Net Noncurrent | - | - | - | - | - | 0 | 0 | - | - | - | 0 | - | ||||||
| Equity Method Investments | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 7 | 9 | 8 | 9 | 12 | 11 | 11 | 10 | 10 | 10 | 8 | 7 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | ||||||
| Long Term Debt Current | - | - | - | 0 | 0 | - | 1 | - | - | - | - | 0 | ||||||
| Contract With Customer Liability Current | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability | - | - | - | - | - | - | - | - | - | 1 | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | ||||||
| Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Liabilities Current | 5 | 5 | 5 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | ||||||
| Long Term Debt Noncurrent | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finance Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Liabilities Noncurrent | 5 | 4 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 9 | 9 | 7 | 6 | 6 | 5 | 4 | 4 | 4 | 5 | 4 | 3 | ||||||
Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 164 | 165 | 165 | 165 | 161 | 158 | 158 | 157 | 154 | 156 | 154 | 153 | ||||||
| Retained Earnings Accumulated Deficit | -166 | -164 | -161 | -158 | -152 | -151 | -150 | -148 | -148 | -148 | -147 | -146 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Stockholders Equity | -2 | 2 | 4 | 3 | 9 | 8 | 6 | 9 | 6 | 5 | 4 | 4 | ||||||
| Minority Interest | -1 | -2 | -3 | -3 | -3 | -3 | -3 | -3 | -0 | -3 | -3 | -3 | ||||||
| Liabilities And Stockholders Equity | 7 | 9 | 8 | 9 | 12 | 11 | 11 | 10 | 10 | 10 | 8 | 7 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 550 | 550 | 550 | 550 | 550 | 550 | 550 | 550 | 550 | 550 | 550 | 550 | ||||||
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 293 | - | ||||||
| Common Stock Shares Issued | 325 | 320 | 317 | 311 | 307 | 302 | 301 | 301 | 298 | 296 | 293 | 289 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBIOLARGO, INC. (BLGO) — SEC Financial Statements & Analysis
BIOLARGO, INC. (BLGO) is a chemicals & allied products company, incorporated in DE. BIOLARGO, INC. trades on OTC as: BLGO. BIOLARGO, INC. (BLGO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, BIOLARGO, INC. carries a market cap of $35.31M, a P/E ratio of -2.06x, a P/B ratio of -19.06x, a P/S ratio of 8.65x, an enterprise value of $33.43M, and an EV/EBITDA multiple of -1.86x. On profitability, it posts a gross margin of 39.93%, an operating margin of -443.97%, a net margin of -419.62%, a Return on Equity (ROE) of -496.28%, a Return on Assets (ROA) of -178.72%, and a Return on Invested Capital (ROIC) of -164.72%. Per share, it reports EPS of $-0.05, free cash flow per share of $-0.03, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -70.95% year-over-year, net income growth of 159.18% year-over-year, and EPS growth of 144.82% year-over-year. On the balance sheet, it maintains a current ratio of 0.73x, a quick ratio of 0.61x, working capital of $-1.27M, a debt-to-equity ratio of -5.08x, a debt ratio of 1.41, an interest coverage ratio of -22.51x, free cash flow of $-10.32M (TTM), and net debt of $-1.88M. Figures sourced from SEC EDGAR.
- Market Cap
- $35.31M
- P/E TTM
- -2.06x
- EPS TTM
- $-0.05
- P/B TTM
- -19.06x
- ROE TTM
- -496.28%
- ROA TTM
- -178.72%
- Debt To Equity
- -5.08x
- Free Cash Flow TTM
- $-10.32M
- Net Revenue TTM Growth 1Y
- -70.95%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIOLARGO, INC. in?
BIOLARGO, INC. (BLGO) operates in the Chemicals & Allied Products industry.
What exchange does BLGO trade on?
BIOLARGO, INC. (BLGO) trades on the OTC.
Where is BIOLARGO, INC. incorporated?
BIOLARGO, INC. is incorporated in DE.
When was BIOLARGO, INC. (BLGO)'s most recent SEC filing?
BIOLARGO, INC. (BLGO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is BLGO's market cap?
BIOLARGO, INC. (BLGO) has a market capitalization of $35.31M as of 2026-06-30.
What is BLGO's EPS (earnings per share)?
BIOLARGO, INC. (BLGO)'s trailing twelve month EPS is $-0.05 as of 2026-06-30.
What is BLGO's ROE (return on equity)?
BIOLARGO, INC. (BLGO)'s trailing twelve month Return on Equity (ROE) is -496.28% as of 2026-06-30.
What is BLGO's ROA (return on assets)?
BIOLARGO, INC. (BLGO)'s trailing twelve month Return on Assets (ROA) is -178.72% as of 2026-06-30.
What is BLGO's ROIC (return on invested capital)?
BIOLARGO, INC. (BLGO)'s trailing twelve month Return on Invested Capital (ROIC) is -164.72% as of 2025-06-30.
What is BLGO's EV/EBITDA?
BIOLARGO, INC. (BLGO)'s trailing twelve month EV/EBITDA is -1.86x as of 2026-06-30.